Departmental Papers (Dental)
Document Type
Journal Article
Date of this Version
2-1-2010
Publication Source
Plant Biotechnology Journal
Volume
8
Issue
2
Start Page
223
Last Page
242
DOI
10.1111/j.1467-7652.2009.00479.x
Abstract
Cholera and malaria are major diseases causing high mortality. The only licensed cholera vaccine is expensive; immunity is lost in children within 3 years and adults are not fully protected. No vaccine is yet available for malaria. Therefore, in this study, the cholera toxin-B subunit (CTB) of Vibrio cholerae fused to malarial vaccine antigens apical membrane antigen-1 (AMA1) and merozoite surface protein-1 (MSP1) was expressed in lettuce and tobacco chloroplasts. Southern blot analysis confirmed homoplasmy and stable integration of transgenes. CTB-AMA1 and CTB-MSP1 fusion proteins accumulated up to 13.17% and 10.11% (total soluble protein, TSP) in tobacco and up to 7.3% and 6.1% (TSP) in lettuce respectively. Nine groups of mice (n = 10/group) were immunized subcutaneously (SQV) or orally (ORV) with purified antigens or transplastomic tobacco leaves. Significant levels of antigen-specific antibody titres of immunized mice completely inhibited proliferation of the malarial parasite and cross-reacted with the native parasite proteins in immunoblots and immunofluorescence studies. Protection against cholera toxin challenge in both ORV (100%) and SQV (89%) mice correlated with CTB-specific titres of intestinal, serum IgA and IgG1 in ORV and only IgG1 in SQV mice, but no other immunoglobulin. Increasing numbers of interleukin-10+ T cell but not Foxp3+ regulatory T cells, suppression of interferon-γ and absence of interleukin-17 were observed in protected mice, suggesting that immunity is conferred via the Tr1/Th2 immune response. Dual immunity against two major infectious diseases provided by chloroplast-derived vaccine antigens for long-term (>300 days, 50% of mouse life span) offers a realistic platform for low cost vaccines and insight into mucosal and systemic immunity.
Copyright/Permission Statement
This is the peer reviewed version of the following article: Davoodi-Semiromi, A., Schreiber, M., Nallapali, S., Verma, D., Singh, N. D., Banks, R. K., … Daniell, H. (2010). Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery. Plant Biotechnology Journal, 8(2), 223–242. http://doi.org/10.1111/j.1467-7652.2009.00479.x, which has been published in final form at http://doi.org/10.1111/j.1467-7652.2009.00479.x. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving http://olabout.wiley.com/WileyCDA/Section/id-820227.html#terms.
Keywords
cholera, malaria, chloroplast, vaccine, oral delivery, lettuce
Recommended Citation
Davoodi-Semiromi, A., Schreiber, M., Nallapali, S., Verma, D., Singh, N. D., Banks, R. K., Chakrabarti, D., & Daniell, H. (2010). Chloroplast-Derived Vaccine Antigens Confer Dual Immunity Against Cholera and Malaria by Oral or Injectable Delivery. Plant Biotechnology Journal, 8 (2), 223-242. http://dx.doi.org/10.1111/j.1467-7652.2009.00479.x
Date Posted: 01 March 2022
This document has been peer reviewed.
Comments
At the time of publication, author Henry Daniell was affiliated with the University of Central Florida. Currently, he is a faculty member at the School of Dental Medicine at the University of Pennsylvania.